Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study

Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing

(2022) Vincenz Scharner et al.   BMC Geriatrics

Quetiapine for primary insomnia: Consider the risks

(2021) Vania Modesto-Lowe et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality

(2021) Jonas Berge et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

(2019) Maximilian Huhn et al.   LANCET

The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)

(2018) Sinéad M Langan et al.   BMJ-British Medical Journal

The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015

(2017) Pål Gjerden et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

International trends in antipsychotic use: A study in 16 countries, 2005–2014

(2017) Óskar Hálfdánarson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Marginal structural models in clinical research: when and how to use them?

(2017) Tyler Williamson et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis

(2017) Marta M. Maslej et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

(2017) Marco Solmi et al.   Therapeutics and Clinical Risk Management

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

(2016) Davy Vancampfort et al.   World Psychiatry

Quetiapine use in adults in the community: a population-based study in Alberta, Canada

(2016) Diane Duncan et al.   BMJ Open

Antipsychotic Treatment of Adults in the United States

(2015) Mark Olfson et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

(2015) Christoph U. Correll et al.   World Psychiatry

Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study

(2015) Christoph U. Correll et al.   World Psychiatry

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis

(2015) Davy Vancampfort et al.   World Psychiatry

The Danish National Patient Registry: a review of content, data quality, and research potential

(2015) Morten Schmidt et al.   Clinical Epidemiology

Quetiapine for insomnia: A review of the literature

(2014) S. L. Anderson et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

The Danish Civil Registration System as a tool in epidemiology

(2014) Morten Schmidt et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Prescribing of antipsychotics in UK primary care: a cohort study

(2014) Louise Marston et al.   BMJ Open

Effects of Selective Serotonin Reuptake Inhibitors on Platelet Function

(2011) Francisco J. de Abajo   DRUGS & AGING

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

(2011) Marc De Hert et al.   Nature Reviews Endocrinology

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The Danish Register of Causes of Death

(2011) Karin Helweg-Larsen   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics

(2010) C.U. Correll   EUROPEAN PSYCHIATRY

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Immortal Time Bias in Pharmacoepidemiology

(2007) S. Suissa   AMERICAN JOURNAL OF EPIDEMIOLOGY